Hosted on MSN

MIT team finds a way to reboot the immune system

Researchers at MIT have unveiled a way to temporarily reboot aging immune systems, using a targeted mRNA therapy that turns the liver into a short‑lived factory for powerful T‑cell survival signals.
Cure Today

Bria-IMT Combo Shows Survival in Phase 2 Breast Cancer Trial

Bria-IMT plus a checkpoint inhibitor showed a 52% one-year survival rate in metastatic breast cancer patients, surpassing standard therapy outcomes. The treatment was well-tolerated, with no ...
Seeking Alpha

Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals

MILAN and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Genenta Science (GNTA), a pioneer in immuno-oncology, today announced that a total of 38 patients were enrolled in newly diagnosed glioblastoma ...
Seeking Alpha

CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference

VANCOUVER, Washington, Feb. 20, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal ...
WTEN

ImCheck Reports Durable Responses and Early Overall Survival Signal with ICT01 in First-line AML at ASH 2025

Marseille, France, December 7, 2025, 5:30 pm ET/ 11:30 pm CET – ImCheck Therapeutics today announced updated results from its Phase I/II EVICTION study evaluating ICT01, a first-in-class γ9δ2 T-cell ...